Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 209 clinical trials
featured
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

  • 1950 views
  • 25 Mar, 2021
  • 107 locations
featured
Prostate Cancer

Prostate Cancer

  • 72 views
  • 08 Nov, 2020
  • 1 location
featured
A Randomized, Open Label Study Comparing the Combination of YONDELIS® and DOXIL®/CAELYX® with DOXIL®/CAELYX® Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

A Randomized, Open Label Study Comparing the Combination of YONDELIS® and DOXIL®/CAELYX® with DOXIL®/CAELYX® Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • 644 views
  • 08 Nov, 2020
  • 5 locations
A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2

The purpose of the study is to compare the efficacy and safety of standard chemotherapy regimen 2HRZE/4HR plus IL-2 and standard regimen 2HRZE/4HR for newly diagnosed smear positive pulmonary

  • 0 views
  • 04 Mar, 2021
  • 16 locations
Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma

(combination chemotherapy) may kill more tumor cells. It is not yet known which combination chemotherapy regimen is more effective in treating rhabdomyosarcoma. PURPOSE: This randomized phase III

ifosfamide
dactinomycin
carboplatin
cancer chemotherapy
combination chemotherapy
  • 103 views
  • 07 Nov, 2020
  • 9 locations
Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

(combination chemotherapy) may kill more cancer cells. It is not yet known which combination chemotherapy regimen is more effective in treating acute lymphoblastic leukemia. PURPOSE: This randomized

pegaspargase
cyclophosphamide
cancer
mercaptopurine
lymphoid leukemia
  • 1 views
  • 07 Nov, 2020
  • 5 locations
A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer

of completion of the 3 month modified FOLFIRINOX chemotherapy regimen. Randomization will be conducted centrally. Subjects will be randomized in a 1:1 ratio and must be found to have no evidence of

pancreatic adenocarcinoma
folfirinox
adenocarcinoma
  • 1 views
  • 25 Jan, 2021
  • 8 locations
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor

so it can be removed during surgery. Giving more chemotherapy after surgery may kill any remaining tumor cells. It is not yet known which chemotherapy regimen after surgery is most

tumor cells
nephroblastoma
cyclophosphamide
conventional surgery
  • 9 views
  • 07 Nov, 2020
  • 1 location
Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

combination chemotherapy regimen is more effective in treating young patients with acute lymphoblastic leukemia. PURPOSE: This randomized phase III trial is studying different risk-adjusted

prednisone
cyclophosphamide
graft-versus-tumor
cancer
mercaptopurine
  • 0 views
  • 07 Nov, 2020
  • 1 location
Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma

recurrence between the observation group and the treatment group will be compared. Regimen of the adjuvant chemotherapy: The most commonly used 1st line chemotherapy regimen which is

  • 10 views
  • 08 Nov, 2020
  • 1 location